Imithamo yokugomela i-COVID-19 engaphezu kwe-142m elawulwa kulo lonke elaseChina

I-China isinikeze imithamo eyizigidi eziyi-102.4 yokugomela i-COVID-19 kusukela ngoMashi 27, kusho iNational Health Commission yaseChina ngeSonto.

 

Ukuhlinzekwa komhlaba wonke kwemijovo emibili yokugomela i-COVID-19 eyenziwe yizinkampani ezingaphansi kweSinopharm yaseChina kudlule izigidi eziyi-100, inkampani eyodwa imemezele ngoLwesihlanu.Amazwe nezifunda ezingamashumi amahlanu zigunyaze imigomo ye-Sinopharm ukuze isetshenziswe kwezohwebo noma eziphuthumayo, futhi imithamo engaphezu kwezigidi ezingama-80 yale mithi yokugoma emibili inikezwe abantu abavela emazweni angaphezu kwe-190.

 

I-China ibilokhu iqinisa uhlelo lwayo lokugoma ukuze kwakhiwe isivikelo esibanzi sokuzivikela komzimba, kusho uWu Liangyou, iphini likamqondisi wehhovisi lokulawula izifo le-NHC.Lolu hlelo lugxile emaqenjini abalulekile, okuhlanganisa abantu abasemadolobheni amakhulu noma aphakathi nendawo, amadolobha asechwebeni noma ezindaweni ezisemngceleni, abasebenzi bezinkampani zikahulumeni, abafundi basemakolishi nabafundisi, kanye nabasebenzi basezitolo ezinkulu.Abantu abangaphezu kweminyaka engama-60 noma abanezifo ezingelapheki bangathola futhi ukujova ukuze bavikeleke egciwaneni.

 

Ngokusho kukaWu, imithamo yokugoma engu-6.12 million inikezwe ngoLwesihlanu.

 

Umthamo wesibili kufanele unikezwe emasontweni amathathu kuya kwayisishiyagalombili ngemuva kokudubula kokuqala, uWang Huaqing, uchwepheshe omkhulu wohlelo lokugoma eSikhungweni SaseChina Sokulawulwa Kwezifo Nokuvimbela, welulekwe esithangamini sabezindaba sangeSonto.

 

Abantu bayelulekwa ukuthi bathole imithamo emibili yomgomo ofanayo, kusho uWang, wengeza ngokuthi wonke umuntu ofanele ukugonywa kufanele athole isibhamu ngokushesha okukhulu ukuze akhe umhlambi wokugonywa.

 

Imithi yokugomela emibili ye-Sinopharm ibonakale isebenza ngempumelelo ekulweni nezinhlobo ezingaphezu kwe-10 ezitholakala e-UK, eNingizimu Afrika nakwezinye izindawo, kusho uZhang Yuntao, iphini likamongameli weChina National Biotec Group, esebenzisana neSinopharm.

 

Ukuhlolwa okwengeziwe kuyaqhubeka mayelana nezinhlobonhlobo ezitholakala eBrazil naseZimbabwe, kusho uZhang.Idatha yocwaningo lwemitholampilo yezingane ezineminyaka emi-3 kuye kweyi-17 ihlangabezane nalokho obekulindelekile, iphakamisa ukuthi iqembu lingafakwa ohlelweni lokugoma maduze nje, wengeza uZhang.